PolyActiva Inks $9.5M
PolyActiva has raised AUD $9.2 million ($9.5 million) in Series B financing. Investors including the Medical Research Commercialisation Fund, Brandon Biosciences Fund 1, Yuuwa Capital and angel investors. The Australian company will use the infusion to continue preclinical and clinical development programs, which are aimed at treating eye infections.
19 February 2013•4 mins read
